:format(webp))
Let’s move precision oncology forward – together.
We partner with ambitious teams to develop first-in-class cancer therapeutics. Whether you’re looking to access novel, data-driven assets or cocreate breakthrough programs, we’re your R&D partner for successful drug development.
Partnering opportunitiesYour next breakthrough starts with us.
We bring together scientific expertise and data depth to decipher the complexity of cancer. With a patient-first mindset and a focus on collaboration, we can drive innovative R&D programs faster, smarter, and with greater confidence toward the clinic and beyond.
)
Built for translationAccess unique drug assets.
Grounded in patient insights, our portfolio includes validated targets, customized screening assays, and optimized hit molecules – designed to accelerate discovery and de-risk development. Flexible partnering and licensing options give you the opportunity to unlock our assets.
)
Grounded in patient-driven insightsCocreate novel pipelines.
Together, we can build new drug programs from the very beginning – starting with disease biology, patient data, and novel targets. From discovery through to the clinic, we’re equipped to successfully drive the R&D journey with you.
:format(webp))
“Our targets will have a huge impact on future cancer treatments. We have come a long way, but collaboration is key to making the vision a reality.”